title: Indomethacin inhibits the effects of dietary supplementation with marine oils on vasoconstriction of human forearm resistance vessels in vivo.
abstract: OBJECTIVE
  Dietary supplementation with marine oils attenuates the responses to noradrenaline and angiotensin II in human forearm resistance arteries. The mechanisms underlying these effects were the subject of the present study.
  
  
  METHODS
  Twenty-two normal male adults were allocated to one of three groups. The first group (n = 11) received 10 g/day marine oil capsules (maxEPA) for 28 days. The second group (n = 7) received maxEPA plus 25 mg indomethacin three times a day on days 28 and 29. The third group (n = 4) received 10 g/day mixed-oil placebo capsules for 28 days, plus indomethacin on days 28 and 29 as in group 2. Forearm venous occlusion plethysmography was performed before and immediately after each treatment period.
  
  
  RESULTS
  Responses to acetylcholine, sodium nitroprusside or reactive hyperaemia (area under the time-response curve: pre-maxEPA 14,850 +/- 3502, post-maxEPA 17,118 +/- 4576 units) were unaffected by maxEPA. The suppressive effect of maxEPA on responses to noradrenaline and angiotensin II (from group 1) was no longer apparent in the group receiving indomethacin in addition to maxEPA. Indomethacin, in subjects on placebo capsules, had no effect on the responses to either agonist.
  
  
  CONCLUSIONS
  We conclude that the suppressive effects of maxEPA result from alterations to in vivo prostanoid profiles.
authors.affiliation: Alfred and Baker Medical Unit, Baker Medical Research Institute, Prahran, Victoria, Australia.
authors.forename: J P
authors.initials: JP
authors.lastname: Chin
authors.forename: A P
authors.initials: AP
authors.lastname: Gust
authors.forename: A M
authors.initials: AM
authors.lastname: Dart
mesh_terms: D000293:Adolescent; D000328:Adult; D004281:Docosahexaenoic Acids; D004338:Drug Combinations; D015118:Eicosapentaenoic Acid; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology*; D005395:Fish Oils / Q000494:pharmacology*; D005542:Forearm / Q000098:blood supply; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D008297:Male; D014655:Vascular Resistance; D014661:Vasoconstriction / Q000187:drug effects*
chemical_list: D004338:Drug Combinations; D015525:Fatty Acids, Omega-3; D005395:Fish Oils; C045153:Maxepa; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid; D007213:Indomethacin